US Stocks
/
Larimar Therapeutics, Inc. Share Price

Larimar Therapeutics, Inc. Share Price

NASDAQ: LRMR | Micro Cap
$2.66
-$0.02 (-0.93%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Larimar Therapeutics, Inc. Stock Performance

Open
$2.71
Prev. Close
$2.69
Circuit Range
N/A
Day Range
$2.63 - $2.73
Year Range
$2.62 - $6.42
Volume
83,282
Average Traded
$2.68

Larimar Therapeutics, Inc. Share Price Today

As of 11 October 2026, Larimar Therapeutics, Inc.'s share price is $2.66. The stock opened at $2.71, compared to its previous close of $2.69. During today's trading session, Larimar Therapeutics, Inc.'s share price traded between $2.63 and $2.73, with an average price of $2.68. Over the past 52 weeks, the stock has recorded a high of $6.42 and a low of $2.62. In terms of performance, Larimar Therapeutics, Inc.'s share price has declined by 34.47% over the last six months and is down 31.79% on a year-on-year basis.

Larimar Therapeutics, Inc. Share Price Chart

$2.63$2.73
L
Show Current Price
H

Larimar Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$665000.00
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.66
Revenue (TTM)
$0.00
Return On Equity (TTM)
-135.50%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
31.29%

Larimar Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$47.71-$62.50-$29.61-$32.78
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-31.00%52.62%-10.71%

Larimar Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$35.36-$36.95-$80.60-$165.67
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-4.50%-118.13%-105.55%

About Larimar Therapeutics, Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.

Larimar Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.17
$2.67
-16.72%
Sep 2026
$3.80
$3.20
-20.79%
Aug 2026
$3.81
$4.04
+5.62%
Jul 2026
$3.07
$3.83
+25.82%
Jun 2026
$3.45
$3.04
-12.77%
May 2026
$4.03
$3.48
-14.14%
Apr 2026
$4.62
$4.06
-9.80%
Mar 2026
$5.00
$4.50
-15.25%
Feb 2026
$3.48
$5.31
+50.42%
Jan 2026
$3.71
$3.53
-7.47%
Dec 2025
$3.41
$3.81
+7.46%
Nov 2025
$3.95
$3.55
-8.97%

LRMR Share Price FAQs

What is Larimar Therapeutics, Inc. share price today?

chevron-up
Larimar Therapeutics, Inc. share price today is $2.66 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Larimar Therapeutics, Inc. stock?

chevron-up
The 52 week high of Larimar Therapeutics, Inc. stock is $6.42, while the 52 week low is $2.62 as of 10 Oct '26.

What is LRMR's market capitalisation today?

chevron-up
LRMR market capitalisation is $665000.00 as of October 11, 2026, at 2:04 am IST.

What is LRMR's net income for the last quarter?

chevron-up
LRMR's net income for the last quarter is -32.78B USD.

What is the 5 year returns of LRMR?

chevron-up
The 5 year returns of LRMR is -77.74% as on 10 Oct '26.

What is the high & low stock price of LRMR today?

chevron-up
LRMR stock price hit a high of $2.73 and low of $2.63 as of 10 Oct '26.

Can I buy LRMR shares in India?

chevron-up
Yes. You can buy LRMR in India by opening an international trading account.